| 查看: 476 | 回复: 0 | |||
kidant
|
[交流]
【转帖】5.1FDA召回部分婴幼儿产品（含泰诺林）
|
|
FDA原文（http://www.fda.gov/NewsEvents/Ne ... ments/ucm210441.htm）： FDA NEWS RELEASE For Immediate Release: May 1, 2010 Media Inquiries: Elaine Ganz Bobo, 240.620.6896, Elaine.Bobo@fda.hhs.gov Consumer Inquiries: 888-INFO-FDA FDA provides consumer advice following recall of products for infants and children Working in consultation with the United States Food and Drug Administration (FDA), McNeil Consumer Healthcare is implementing a voluntary recall of infant and children’s liquid products due to manufacturing deficiencies which may affect quality, purity or potency. Following McNeil’s recall announcement on Friday evening, the FDA is providing additional advice to consumers. “We want to be certain that consumers discontinue using these products and that they know what to do if they have concerns about a specific product,” said Commissioner of Food and Drugs Margaret A. Hamburg, M.D. “While the potential for serious health problems is remote, Americans deserve medications that are safe, effective and of the highest quality. We are investigating the products and facilities associated with this recall and will provide updates as we learn more.” What products are affected by this recall? The products include certain liquid infant’s and children’s Tylenol®, Motrin®, Zyrtec®, and Benadryl® products. For a complete list of recalled products, please see the recall notice1. Why were these products recalled? McNeil Consumer Healthcare is initiating this voluntary recall because some of these products may not meet required quality standards. As a precautionary measure, parents and caregivers should not administer these products to their children. Some of the products included in the recall may contain a higher concentration of active ingredient than specified; others contain inactive ingredients that may not meet internal testing requirements; and others may contain tiny particles. While the potential for serious medical events is remote, FDA advises consumers who have purchased these recalled products to discontinue use. What can I use instead of the recalled products? There are a number of other products on the market, including generic versions of the recalled products, which are intended for use in infants and children and are not affected by the recall. FDA recommends that you check the labeling of these products. If you have any questions, you should discuss this with your pharmacist or other health care professional. FDA does not anticipate that there will be a shortage of alternative products. Can I give my child adult strength Tylenol® or Motrin® products that are not being recalled? No. Consumers should not give drug products to infants and children that are not intended for those age groups. This could result in serious harm. What should I do if I have some of the medication at home? FDA recommends that consumers stop using these products. For further instructions, see McNeil’s website at: www.mcneilproductrecall.com2 I gave my child some of the medication. What do I do? Is my child at risk? According to the information the FDA has received at this time, the potential for serious medical problems is remote. If your child exhibits any unexpected symptoms after use of any of the recalled products, contact your health care professional. If I think my child may be having an adverse reaction to one of the products involved in this recall, who should I notify? Adverse reactions or quality problems experienced with the use of these products may be reported to FDA's MedWatch Adverse Event Reporting program either online, by regular mail, or by fax, using the contact information at the bottom of this sheet. The agency asks health care professionals and consumers to report any adverse reactions to the FDA’s MedWatch Program by fax at 1-800-FDA-0178, by mail at MedWatch, FDA, 5600 Fishers Lane, Rockville, MD 20852-9787, or on the MedWatch website at www.fda.gov/medwatch3. Related information: Facts about Current Good Manufacturing Practices (CGMPs)4 |
回复此楼» 猜你喜欢
全新推出Tguide®靶向递送方案，突破99% T细胞转染效率
已经有1人回复
-
Mal-LN29-LNP-mRNA 试剂盒：自带Mal基团，一盒实现抗体筛选与体内靶向验证
已经有0人回复
-
药理学论文润色/翻译怎么收费?
已经有99人回复
-
自由偶联 | 脾脏靶向：抗体偶联空载LNP试剂盒
已经有0人回复
-
SM-102 试剂盒，告别纳米制备仪！
已经有0人回复
-
2026年辅料登记预告
已经有1人回复
-
SPguide®：小鼠体内脾脏转染的一键解决方案
已经有0人回复
-
高效肺靶向RNA转染，加速肺部RNA药物开发
已经有2人回复
-
二糖的糖脂，合成后sephadex LH-20分离不出来，求助
已经有1人回复
-
南方医科大学珠江医院肖计生课题组招收博士生 （2026年入学）
已经有1人回复
找到一些相关的精华帖子，希望有用哦~
MS5.5 License安装
已经有4人回复
- 求助，婴幼儿配方乳中美拉德反应的控制
已经有9人回复
- 为什么药品召回美国多中国少?
已经有14人回复
- 【求助】我用铁粉还原5-硝基苯甲酸，怎么出不来产品
已经有4人回复
点击这里搜索更多相关资源科研从小木虫开始，人人为我，我为人人